Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 and <sup>18</sup>F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study

L. Giesel, Frederik; Will, Leon; O. Lawal, Ismaheel; Lengana, Thabo; Kratochwil, Clemens; Vorster, Mariza; Neels, Oliver; Reyneke, Florette; Haberkon, Uwe; Kopka, Klaus; Sathekge, Mike

doi:10.2967/jnumed.117.204669

Public

Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study

Published in Journal of Nuclear Medicine • Dec 21, 2017

Authors:

Frederik L. Giesel

Leon Will

Ismaheel O. Lawal

Abstract

The introduction of 18F-labeled prostate-specific membrane antigen (PSMA)–targeted PET/CT tracers, first 18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid) and more recently 18F-PSMA-1007 (((3S,10S,14S)-1-(4-(((S)-4-carboxy-2-((S)-4-carboxy-2-...

Subject

Prostate cancer

Lymph node

Nuclear medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!